Omnicare, the nation's largest supplier of drugs to nursing homes, agreed to pay $120 million to settle allegations that it gave improper discounts on some Medicare patients' drugs in exchange for being able to provide drugs to other people in the same long-term-care facilities.
Omnicare did not admit any wrongdoing, according to a filing with the Securities and Exchange Commission.
The settlement does not resolve allegations in scores of other False Claims Act lawsuits pending against the Covington, Ky.-based company. In one filed in U.S. District Court in Houston, Ruscher v. Omnicare, plaintiffs suing on behalf of 22 states and the federal government allege the company forgave debts for lower-acuity patients in order to secure business for more lucrative ones. Omnicare denies the allegations.